Vascular endothelial growth factor is involved in angioedema associated with eosinophilia

Kurume Medical Journal

Volumn 52, Issue 3, 2005, Pages 89-91

  Harada, Masaru ^a   Kumemura, Hiroto ^a   Yanagimoto, Chikatoshi ^a   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angioedema; Eosinophilia; Vascular endothelial growth factor

Indexed keywords

CYTOKINE; INTERLEUKIN 5; PREDNISOLONE; VASCULOTROPIN;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EOSINOPHILIA; FEMALE; HUMAN; MALE; PATHOGENESIS; PERIPHERAL EDEMA; PROTEIN BLOOD LEVEL; RARE DISEASE; SYMPTOMATOLOGY;

ADULT; ANGIONEUROTIC EDEMA; EOSINOPHILIA; FEMALE; HUMANS; INTERLEUKIN-5; MALE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 32844464373     PISSN: 00235679     EISSN: None     Source Type: Journal    
DOI: 10.2739/kurumemedj.52.89     Document Type: Article

References (12)

1. Gleich GJ, Schroeter AL, Marcoux JP, Sachs MI, O'Connell EJ et al. Episodic angioedema associated with eosinophilia. N Engl J Med 1984; 310:1621-1626.
2. Butterfield JH, Leiferman KM, Abrams J, Silver JE, Bower J et al. Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood 1992; 79:688-692.
3. Murakami T, Kato J, Kogawa K, Watanabe N, Sakamaki S et al. Increased serum level of interleukin-5 in a patient with episodic angioedema and eosinophilia syndrome. Intern Med 1993; 32:343-345.
4. Okubo Y, Sato E, Hossain M, Ota T, Yoshikawa S et al. Periodic angioedema with eosinophilia: increased serum level of interleukin 5. Intern Med 1995; 34:108-111.
5. Chikama R, Hosokawa M, Miyazawa T, Miura R, Suzuki T et al. Nonepisodic angioedema associated with eosinophilia: report of 4 cases and review of 33 young female patients reported in Japan. Dermatology 1998; 197:321-325.
6. Dvorak HF, Brown LF, Detmar M, and Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146:1029-1039.
7. Thomas KA. Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 1996; 271:603-606.
8. Clutterbuck EJ, Hirst EM, and Sanderson CJ. Human interleukin-5 [IL-5] regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood 1989; 73:1504-1512.
9. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG et al. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988; 167:219-224.
10. Moqbel R, Levi-Schaffer F, and Kay AB. Cytokine generation by eosinophils. J Allergy Clin Immunol 1994; 94:1183-1188.
11. Horiuchi T, and Weller PF. Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol 1997; 17:70-77.
12. Mori A, Kaminuma O, Suko M, Mikami T, Nishizaki Y et al. Two distinct pathways of interleukin-5 synthesis in allergen-specific human T-cell clones are suppressed by glucocorticoids. Blood 1997; 89:2891-2900.